Telescope Innovations Delivers Continued Profitability in Fiscal Quarter 3, 2023
Vancouver, British Columbia–(Newsfile Corp. – June 29, 2023) – Telescope Innovations Corp. (CSE: TELI) (OTCQB:…
News
Watershed Announces Lowercarbon Capital Investment
Lowercarbon Capital to purchase carbon removal from the Watershed Marketplace following their investment in Watershed’s…
Sequans Elects Maria Marced to Board of Directors
Paris, France–(Newsfile Corp. – June 29, 2023) – Sequans Communications S.A. (NYSE: SQNS) announced that…
MineHub Achieves Record Revenue in First Quarter
Management provides a positive outlook based on an expanded sales pipeline and larger market opportunity…
Honda Issues “Honda ESG Data Book 2023”
TOKYO, Jun 29, 2023 – (JCN Newswire) – Honda Motor Co., Ltd. today issued its…
Hitachi Receives Orders for 160 Elevators, Escalators, Moving Sidewalks and Related Systems for the Hong Kong West Kowloon Station Complex
TOKYO, Jun 29, 2023 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501), today announced that…
New Media Lab Announces Proposed Listing on The Main Board of SEHK
HONG KONG, Jun 29, 2023 – (ACN Newswire) – New Media Lab Limited (“New Media…
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily
NEW YORK, Jun 29, 2023 – (ACN Newswire) – Soligenix, Inc. (NASDAQ: SNGX), a late-stage…
33rd Hong Kong Book Fair opens on 19 July
HONG KONG, Jun 29, 2023 – (ACN Newswire) – The 33rd HKTDC Hong Kong Book…
China Medical System Included in the First ‘Sustainability Yearbook (China)’ of S&P Global
l CMS was included into the first “Sustainability Yearbook (China)” published by S&P Global. l…
Solar Powered Sunscreen: EcoZinc a World First in Sustainable Zinc Oxide Innovation
BRISBANE, AUS, Jun 29, 2023 – (ACN Newswire) – Advance ZincTek, Australia’s leading manufacturer of…
Dremio Revolutionizes Data Lakehouse Engine with Cutting-Edge Features, Empowering Faster Insights and Streamlined Operations
Dremio’s new functionality simplifies query construction, optimizes performance and storage use, and enhances compatibility for…
NetApp Recognized as a Finalist in the 2023 Microsoft US Partner of the Year Awards
Microsoft’s prestigious awards program honors NetApp for excellence in providing innovative and unique services or…
Sama Launches Platform 2.0, Delivering 99% Client Acceptance Rate for AI Training Data
Three-pronged approach triples efficiency, leveraging proprietary approach to provide up to 10 billion accurate annotation…
Esri Partners with Databricks to Bring Spatial Analytics Functionality to the Lakehouse Platform
New Partnership Agreement Enables Data Scientists Greater Flexibility to Scale Esri’s ArcGIS Capabilities REDLANDS, Calif.–(BUSINESS…
Domain Therapeutics announces nomination of best-in-class CCR8 antibody candidate, DT-7012, further strengthening its unique portfolio of GPCR-targeting immunotherapies
Domain Therapeutics announces nomination of best-in-class CCR8 antibody candidate, DT-7012, further strengthening its unique portfolio…
Domain Therapeutics announces nomination of best-in-class CCR8 antibody candidate, DT-7012, further strengthening its unique portfolio of GPCR-targeting immunotherapies
Domain Therapeutics announces nomination of best-in-class CCR8 antibody candidate, DT-7012, further strengthening its unique portfolio…
BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related Agitation
Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant…
BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related Agitation
Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant…
MediciNova Announces Presentation of Results from the Phase 2b Trial of MN-166 (ibudilast) in Alcohol Use Disorder at the 46th Annual Research Society on Alcohol (RSA) Scientific Meeting
LA JOLLA, Calif., June 29, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…